Herbal treatments: are there risks for ENT surgery?

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

When using herbal treatments, we should consider not only their beneficial effects, but also the potential for drug interactions. Serious problems may occur when used in combination with anesthetics and therapeutic agents. Some herbal treatments and biologically active supplements containing herbal components may affect the blood coagulation cascade and increase bleeding during endoscopic procedures in the lumen of ENT organs. They may also interact with later prescribed agents. Therefore, when taking the patient’s history, we should ask not only about the use of pharmaceutical agents, but also about the use of dietary supplements, herbal teas, and some herbal products. In some cases, it is necessary to discontinue herbal treatments in advance to avoid complications during general anesthesia and surgery.

Full Text

Restricted Access

About the authors

Leonid V. Kolotilov

Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: leon956@yandex.ru
ORCID iD: 0000-0003-1231-8051

MD, Dr. Sci. (Medicine)

Russian Federation, 2 Litovskaya St., Saint Petersburg, 194100

References

  1. Boyko NN, Bondarev AV, Zhilyakova ET, et al. Phytodrugs, analysis of Russian federation pharmaceutical market. Research Results in Biomedicine. 2017;(4):30–38. EDN: YTVKOT doi: 10.18413/2313-8955-2017-3-4-30-38
  2. Glotov MA. Phytotherapy and anesthesia (internet review). Meditsina neotlozhnykh sostoyanii. 2012;42(3):114–118. EDN: RBRDHJ
  3. Dippenaar JM. Herbal and alternative medicine: the impact on anesthesia. SAJAA. 2015;21(1):8–13. doi: 10.1080/22201181.2015.1013321
  4. Jahromi B, Pirvulescu I, Candido KD, Knezevic NN. Herbal medicine for pain management: efficacy and drug interactions (review). Pharmaceutics. 2021;13:251. doi: 10.3390/pharmaceutics13020251
  5. Hodges PJ, Kam PCA. The perioperative implications of herbal medicines. Anaesthesia. 2002;57:889–899. doi: 10.1046/j.1365-2044.2002.02781
  6. Brevoort P. The booming US botanical market: a new overview. HerbalGram. 1998;44:33–46.
  7. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA. 1998;280:1569–1575. doi: 10.1001/jama.280.18.1569
  8. Richter M. Traditional medicines and traditional healers in South Africa [Internet]. Treatment Action Campaign. 2003. Available from: https://www.academia.edu/2121522/Traditional_medicines_and_traditional_healers_in_South_Africa. Accessed: 13 Oct 2024.
  9. Peltzer K, Friend-du Preez N, Ramlagan S. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008;8:255–269. doi: 10.1186/1471-2458-8-255
  10. Chidiac EJ, Kaddoum RN, Fuleihan SF. Mandragora. Anesth Analg. 2012;115:1437–1441. doi: 10.1213/ANE.0b013e318259ee4d
  11. Pavlov VE, Polushin YuS, Kolotilov LV. Anesthesiological possibilities of intraoperative bleeding control during endoscopic rhinosinusurgical interventions. Messenger of anesthesiology and resuscitation. 2022;19(1):75–81. EDN: DNMUAN doi: 10.21292/2078-5658-2022-19-1-75-81
  12. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 2002;32(6):451–478. doi: 10.1080/00498250210124147
  13. Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet. 1996;31:47–64. doi: 10.2165/00003088-199631010-00004
  14. Zhou SF, Gao YH, Jiang W, et al. Interactions of herbs with cytochrome P450. Drug Metab Rev. 2003;35(1):35–98. doi: 10.1081/DMR-120018248
  15. Jiang X, Williams KM, Liauw WS, et al. Effect of St John’s wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57(5):592–599. doi: 10.1111/bcp.2004.57.issue-5
  16. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2006;65(9):1239–1282. doi: 10.2165/00003495-200565090-00005
  17. American Society of Anesthesiologists. What you should know about herbal and dietary supplement use and anesthesia. 2000 [Internet]. Available from: http://www.asahq.org/patientEducation/herbPatient.pdf. Accessed: 13 Oct 2024.
  18. Lyons TR. Herbal medicines and possible anesthesia interactions. AANA J. 2002;70(1):47–51.
  19. Kam PCA, Liew S. Traditional Chinese herbal medicine and anaesthesia. Anaesthesia. 2002;57:1083–1089. doi: 10.1046/j.1365-2044.2002.02823.x
  20. Ang-Lee MK, Moss J, Yuan C. Herbal medicines and perioperative care. JAMA. 2001;286(2):208–216. doi: 10.1001/jama.286.2.208
  21. Heltemes L. How herbal products increase surgical risk. Nursing. 2007;37(9):24–25. doi: 10.1097/01.NURSE.0000287706.48631.87
  22. Lietman PS. Herbal medicine development. Am J Ther. 2012;19:351–356. doi: 10.1097/MJT.0b013e31825891a0
  23. Harkey MR, Henderson GL, Gershwin ME, et al. Variability in commercial ginseng products: and analysis of 25 preparations. Am J Clin Nutr. 2001;73:1101–1106. doi: 10.1093/ajcn/73.6.1101
  24. Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements. Drug Saf. 1997;17(5):342–356. doi: 10.2165/00002018-199717050-00006
  25. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med. 2001;135(8 Pt 1):594–600. doi: 10.7326/0003-4819-135-8_Part_1-200110160-00010
  26. Valli G, Giardina E-G. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol. 2002;39(7):1083–1095. doi: 10.1016/S0735-1097(02)01749-7
  27. Beckert BW, Concannon MJ, Henry SL, et al. The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature. Plast Reconstr Surg. 2007;120:2044–2050. doi: 10.1097/01.prs.0000295972.18570.0b
  28. Kim SY, Yun-Choi HS. A comparative optical aggregometry study of antiplatelet activity of taxanes from Taxus cuspidate. Thromb Res. 2010;125:e281–284. doi: 10.1016/j.thromres.2009.12.024
  29. Im JH, Jin YR, Lee JJ, et al. Antiplatelet activity of β-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCγ2 phosphorylation. Vascul Pharmacol. 2009;50:147–152. doi: 10.1016/j.vph.2008.11.008
  30. Lee MH, Son YK, Han YN. Tissue factor inhibitory sesquiterpene glycoside from Eriobotrya japonica. Arch Pharm Res. 2004;27:619–623. doi: 10.1007/BF02980160
  31. Medeiros VP, Queiroz KC, Cardoso ML, et al. Sulfated galactofucan from Lobophora variegata: anticoagulant and anti-inflammatory properties. Biochemistry Mosc. 2008;73(9):1018–1024. doi: 10.1134/S0006297908090095
  32. Liao FL, Li B. Inhibition of shear induced platelet aggregation by Chinese herbal medicine. Clin Hemorheol Microcirc. 1997;17(4):315–318.
  33. Mao W, Li H, Li Y, et al. Chemical characteristic and anticoagulant activity of the sulfated polysaccharide isolated from Monostroma latissimum (Chlorophyta). Int J Biol Macromol. 2009;44(1):70–74. doi: 10.1016/j.ijbiomac.2008.10.003
  34. Lietman PS. Herbal medicine development. Am J Ther. 2012;19:351–356. doi: 10.1097/MJT.0b013e31825891a0
  35. Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract ankaferd blood stopper. J Int Med Res. 2008;36:163–170. doi: 10.1177/147323000803600121
  36. Pawlaczyk I, Czerchawski L, Kańska J, et al. An acidic glycoconjugate from Lythrum salicaria L. with controversial effects on haemostasis. J Ethnopharmacol. 2010;131:63–69. doi: 10.1016/j.jep.2010.06.001
  37. Cordier W, Steenkamp V. Herbal remedies affecting coagulation: a review. Pharm Biol. 2012;50(4):443–452. doi: 10.3109/13880209.2011.611145
  38. Lee A, Ci PT, Aun CS, et al. Possible interaction between sevoflurane and Aloe Vera. Ann Pharmacother. 2004;38(10):1650–1654. doi: 10.1345/aph.1E098
  39. Cook NC, Samman S. Flavonoids – chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996;7:66–76. doi: 10.1016/0955-2863(95)00168-9
  40. Tachjian A, Viqar M, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55(10):515–525. doi: 10.1016/j.jacc.2009.07.074
  41. Ghayur M, Gilani AH, Afridi MB, et al. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol. 2005;43(4):234–241. doi: 10.1016/j.vph.2005.07.003
  42. Howard BV, Kritchevsky D. Phytochemicals and cardiovascular disease: a statement for healthcare professionals from the American heart association. Circulation. 1997;95:2591–2593. doi: 10.1161/01.CIR.95.11.2591
  43. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 1. CNS Drugs. 2013;27:207–219. doi: 10.1007/s40263-013-0044-3
  44. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs. 2013;27:301–319. doi: 10.1007/s40263-013-0059-9
  45. Lantz MS, Buchalter E, Giambanco V. St. John’s wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol. 1999;12(1):7–10. doi: 10.1177/089198879901200103
  46. Caldwell SH, Feeley JW, Wieboldt TF, et al. Acute hepatitis with use of over-the-counter herbal remedies. Va Med Q. 1994;121(1):31–33.
  47. Mai I, Krüger H, Budde K, et al. Hazardous pharmacokinetic interaction of Saint John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporine. Int J Clin Pharmacol Ther. 2000;38(10):500–502. doi: 10.5414/CPP38500
  48. Berginc K, Milisav I, Kristl A. Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir. Drug Metab Pharmacokinet. 2010;25(6):521–530. doi: 10.2133/dmpk.dmpk-10-rg-053
  49. Kudolo GB. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic β-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol. 2001;41(6):600–611. doi: 10.1177/00912700122010483
  50. Homma M, Oka K, Ikeshima K, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol. 1995;47(8):687–692. doi: 10.1111/jphp.1995.47.issue-8
  51. Elinav E, Chajek-Shaul T. Licorice consumption causing severe hypokalemic paralysis. Mayo Clin Proc. 2003;78(6):767–768. doi: 10.4065/78.6.767
  52. Steenkamp V, Stewart MJ. Medicinal applications and toxicological activities of aloe products. Pharm Biol. 2007;45(5):411–420. doi: 10.1080/13880200701215307
  53. Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry. 1995;58(5):639–640. doi: 10.1136/jnnp.58.5.639
  54. Teschke R, Frenzel C, Schulze J, et al. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol. 2013;19(19):2864–2882. doi: 10.3748/wjg.v19.i19.2864
  55. Barone GW, Gurley BJ, Ketel BL, et al. Drug interaction between St John’s wort and cyclosporine. Ann Pharmacother. 2000;34(9):1013–1016. doi: 10.1345/aph.10088
  56. Kleinschmidt S, Rump G, Kotter J. Herbal medications. Anaesthesist. 2007;56(12):1257–1266. (In German) doi: 10.1007/s00101-007-1264-z
  57. Posadzki P, Watson L, Ernst E. Herb – drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2012;75(3):603–618. doi: 10.1111/j.1365-2125.2012.04350.x
  58. Oga EF, Shuichi S, Shitara Y, Toshiharu H. Pharmacokinetic herb-drug interactions: insight into mechanisms and consequences. Eur J Drug Metab Pharmacokinet. 2016;41(2):93–108. doi: 10.1007/s13318-015-0296-z
  59. Galeotti N, Farzad M, Bianchi E, Ghelardini C. Pkc-mediated potentiation of morphine analgesia by St. John’s wort in rodents and humans. J Pharmacol Sci. 2014;124:409–417. doi: 10.1254/jphs.13226FP
  60. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacoter. 2000;34(12):1478–1482. doi: 10.1345/aph.10031
  61. Johne A, Schmider J, Brockmöller J, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John’s wort (Hypericum perforatum). Clin Psychopharmacol. 2002;22(1):46–54. doi: 10.1097/00004714-200202000-00008
  62. Sarris J, Kavanagh DJ. Kava and St John’s wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med. 2009;15(8):827–836. doi: 10.1089/acm.2009.0066
  63. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134–138. doi: 10.1016/S0140-6736(99)06457-0
  64. Skinner CM, Rangasami J. Preoperative use of herbal medicines: a patient survey. Br J Anaesth. 2002;89(5):792–795.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download